Moneycontrol PRO

business

Sun Pharma Q2 show healthy but margins unsustainable: Nangra

Healthcare major Sun Pharmaceutical Industries' Profit more than doubled to Rs 2,235.1 crore in the quarter ended September 2016 compared with Rs 1,028.8 crore in year-ago period, driven by overall healthy business performance.

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Sections
ISO 27001 - BSI Assurance Mark